TCL Archive Cancer clinical trials cooperative groups are in jeopardy, and changes are needed to enable the system to survive, chairmen of the groups wrote in a paper submitted to NCI. White paper makes 25 recommendations, including changing system incentives, review process, group integration with centers and SPOREs, and inclusion in CaBIG. This 8-page issue includes full text of the white paper. April 2, 2004
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Congress: Conferees Approve 42 billion Increase For NIH Appropriations October 29, 1999
TCL Archive In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA October 15, 1982
TCL Archive Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues October 8, 1982
